The biggest study to date—a large Danish study—published in 2015, involving 1462 individuals, demonstrated a reduced GLP-1 response to an OGTT in prediabetes, screen-detected type 2 diabetes, and obese and overweight individuals compared to normal glucose-tolerant individuals and normal weight individuals, respectively [9]. The gene discussed is GCG; the disease is prediabetes syndrome.